Nitric oxide inhibits isoprenaline-induced positive inotropic effects in normal, but not in hypertrophied rat heart

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 357, Issue 5, 1998, Pages 579-583

  Kotchi Kotchi, E ^a   Weisselberg, T ^a   Rohnert P ^a   Preiss, M ^a   Heinroth Hoffmann, I ^a   Osten, B ^a   Brodde, O E ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

5 6 Nephrectomy; Aortic banding; Cardiac hypertrophy; NO; SHR

Indexed keywords

ISOPRENALINE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; INOTROPISM; MYOFILAMENT; NEPHRECTOMY; NEUROTRANSMITTER RELEASE; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

EID: 0031748949     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005211     Document Type: Article

References (24)

1. Amann K, Irzyniec T, Mall G, Ritz E (1993). The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis. J Hypertens 11: 969-976
2. Belhassen L, Kelly RA, Smith TW, Balligand J-L (1996). Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. J Clin Invest 97: 1908-1915
3. Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE (1993). Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: H176-H182
4. Brown L, Deighton NM, Bals S, Söhlmann W, Zerkowski H-R, Michel MC, Brodde O-E (1992). Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol 19: 222-232
5. Ecker T, Göbel C, Hullin R, Rettig R, Seitz G, Hofmann F (1989). Decreased cardiac concentration of cGMP kinase in hypertensive animals. An index for cardiac vascularization? Circ Res 65: 1361-1369
6. Flesch M, Kilter H, Cremers B, Lenz O, Südkamp M, Kuhn-Regnier F, Böhm M (1997). Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmacol Exp Ther 281: 1340-1349
7. Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinen H (1994). Nitric oxide synthase isozymes: characterization, molecular cloning and functions. Hypertension 23: 1121-1131
8. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM (1994). Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 267: H1804-H1813
9. Inui J, Brodde O-E, Schümann HJ (1982). Influence of acetylcholine on the positive inotropic effect evoked by α-or β-adrenoceptor stimulation in the rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 320: 152-159
10. Ito N, Bartunek J, Spitzer KW, Lorell BH (1997). Effects of nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes. Circulation 95: 2303-2311
11. Mann JFE, Jakobs KH, Riedel J, Ritz E (1986). Reduced chronotropic responsiveness of the heart in experimental uremia. Am J Physiol 250: H846-H852
12. Marczin N, Ryan US, Catravas JD (1992). Methylene blue inhibits nitrovasodilator-and endothelium-derived relaxing factor-induced cyclic AMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of Superoxide anion. J Pharmacol Exp Ther 263: 170-179
13. Marshall JJ, Wei EP, Konton HA (1988). Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide. Am J Physiol 255: H847-H855
14. 1-but not to β-adrenoceptor stimulation in isolated hearts from spontaneously hypertensive rats. J Hypertens 10: 143-148
15. Mertens MJF, Mathy M-J, Pfaffendorf M, van Zwieten PA (1992b) Depressed inotropic response to beta-adrenoceptor agonists in the presence of advanced cardiac hypertrophy in hearts from rats with induced aortic stenosis and from spontaneously hypertensive rats. J Hypertens 10: 1361-1368
16. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268: 26286-26295
17. Rambausek M, Ritz E, Mall G, Mels O, Katus H (1985). Myocardial hypertrophy in rats with chronic renal insufficiency. Kidney Int 28: 775-787
18. Schmidt HH, Lohmann SM, Walter U (1993). The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1178: 153-175
19. Sen S, Tarazi RC, Khairallah PA, Bumpus FM (1974). Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 35: 775-781
20. Silberberg JS, Barre PE, Prichard SS, Sniderman AD (1989). Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290
21. Smith HJ, Nuttall A (1985). Experimental models of heart failure. Cardiovasc Res 19: 181-186
22. Spitzer KW, Bridge JHB (1992). Relationship between intracellular pH and tension development in resting ventricular muscle and myocytes. Am J Physiol 262: C317-327
23. Sun X, Wei S, Szabo C, Dusting GJ (1997). Depression of the inotropic action of isoprenaline by nitric oxide synthase induction in rat isolated heart. Eur J Pharmacol 320: 29-35
24. Van Rossum JM (1963). Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch int Pharmacodyn Ther 143: 299-330